Company Analysis Sundrug Co.,Ltd.
1. Summary
Advantages
- Dividends (4.33%) are higher than the sector average (2.86%).
- The stock's return over the last year (3.23%) is higher than the sector average (0%).
- The company's current efficiency (ROE=11.9%) is higher than the sector average (ROE=1.13%)
Disadvantages
- Price (4368 Β₯) is higher than fair price (2997.05 Β₯)
- Current debt level 8.33% has increased over 5 years from 0.0732%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
Sundrug Co.,Ltd. | Healthcare | Index | |
---|---|---|---|
7 days | -1.1% | 0% | 0.1% |
90 days | -2.3% | 6.1% | 25.6% |
1 year | 3.2% | 0% | -4.8% |
9989 vs Sector: Sundrug Co.,Ltd. has outperformed the "Healthcare" sector by 3.23% over the past year.
9989 vs Market: Sundrug Co.,Ltd. has outperformed the market by 8.04% over the past year.
Stable price: 9989 is not significantly more volatile than the rest of the market on "Tokyo Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 9989 with weekly volatility of 0.0622% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (4368 Β₯) is higher than the fair price (2997.05 Β₯).
Price is higher than fair: The current price (4368 Β₯) is 31.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (18.74) is lower than that of the sector as a whole (112.41).
P/E vs Market: The company's P/E (18.74) is lower than that of the market as a whole (150.15).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.16) is lower than that of the sector as a whole (70.29).
P/BV vs Market: The company's P/BV (2.16) is lower than that of the market as a whole (120.08).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.726) is lower than that of the sector as a whole (75.54).
P/S vs Market: The company's P/S indicator (0.726) is lower than that of the market as a whole (120.98).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (9.04) is lower than that of the sector as a whole (29.32).
EV/Ebitda vs Market: The company's EV/Ebitda (9.04) is lower than that of the market as a whole (120.75).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.59% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.59%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.61%).
5.4. ROE
ROE vs Sector: The company's ROE (11.9%) is higher than that of the sector as a whole (1.13%).
ROE vs Market: The company's ROE (11.9%) is higher than that of the market as a whole (9.39%).
5.5. ROA
ROA vs Sector: The company's ROA (7.46%) is higher than that of the sector as a whole (0.6587%).
ROA vs Market: The company's ROA (7.46%) is higher than that of the market as a whole (4.46%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (16.11%) is higher than that of the sector as a whole (9.07%).
ROIC vs Market: The company's ROIC (16.11%) is higher than that of the market as a whole (8.83%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 4.33% is higher than the average for the sector '2.86%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 4.33% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 4.33% has been growing weakly or stagnant over the past 5 years. Growth over only 3 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (42.95%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription